Evidence map›Paper›PMID 41184868›Full record

Observational studyBMC medicine2025

Rheumatoid arthritis and cardiovascular disease associations in the UK Biobank.

Janek Salatzki, Dorina-Gabriela Condurache, Stefania D'Angelo, Ahmed M Salih, Liliana Szabo, Adil Mahmood, Elizabeth M Curtis, Steffen E Petersen, Andre Altmann, Norbert Frey and 3 more

Abstract readObservational Study
In one paragraph

Observational study in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Janek Salatzki *William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Dorina-Gabriela Condurache *William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Stefania D'Angelo *MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, SO16 6YD, UK.
Ahmed M Salih *William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Liliana SzaboWilliam Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Adil MahmoodWilliam Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Elizabeth M CurtisMRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, SO16 6YD, UK.
Steffen E PetersenWilliam Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Andre AltmannDepartment of Medical Physics and Biomedical Engineering, The UCL Hawkes Institute, University College London, London, UK.
Norbert FreyDepartment of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, 69120, Heidelberg, Germany.
Florian AndréDepartment of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, 69120, Heidelberg, Germany.
Nicholas C Harvey *MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, SO16 6YD, UK.
Zahra Raisi-Estabragh *William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK. zahraraisi@doctors.org.uk.

Funding

Barts Charity G-002389Barts Charity G-002530, G-002777British Heart Foundation Clinical Research Training Fellowship FS/17/81/33318Medical Research Council MC_PC_21003; MC_PC_21001National Institute for Health and Care Research Barts Biomedical Research Centre NIHR203330National Institute for Healthcare Research (NIHR) Integrated Academic Training ACF-2022-19-003NIHR Integrated Academic Training programme CL-2021-19-00
6 · The paper itself

Abstract

backgroundThis study evaluated observational and causal relationships between rheumatoid arthritis (RA) and cardiovascular disease and imaging phenotypes in the UK Biobank.

methodsRA was defined using linked hospital records, self-reported diagnostics, and medication data. Controls were participants without a record of RA. Cardiovascular diseases (CVDs) were defined using linked hospital records over an average of 14 years of prospective follow-up, including: ischaemic heart diseases (IHD), acute myocardial infarction (AMI), atrial fibrillation, any arrhythmia, non-ischaemic cardiomyopathies, pericardial disease, stroke, peripheral vascular disease, and venous thromboembolism. For participants with cardiovascular magnetic resonance (CMR) available as part of the UK Biobank Imaging Study, we considered measures of cardiac structure and function extracted using automated pipelines. Associations of RA with prevalent and incident CVDs were calculated using logistic and Cox regression. Linear regression was used to examine associations with CMR metrics. Models were adjusted for demographic, lifestyle, and clinical confounders. Causal associations were assessed using two-sample Mendelian randomisation. Genetic instruments for RA (22,350 cases and 74,823 controls), nine CVDs (FinnGen, n = 224,737), and 11 CMR phenotypes (UK Biobank) were extracted and associations assessed using inverse-variance weighting with pleiotropy adjustments and multiple testing corrections.

resultsThe analysis included 1,436 RA cases (mean age 59.9 years; 70.6% female) and 476,975 controls (mean age 56.5 years; 54.3% female). Participants with RA lived in more socioeconomically deprived areas (as per the Townsend Deprivation Index), had lower physical activity levels, were more likely to smoke, and had a higher baseline prevalence of CVDs. In fully adjusted models, participants with RA had a significantly higher hazard of multiple incident CVDs, with the greatest risks related to pericardial disease (HR 2.63 (1.85, 3.74)), heart failure (HR 1.68 (1.42, 1.99)), and AMI (HR 1.53 (1.20, 1.96)). Mendelian Randomisation analyses supported causal links between RA and AMI (OR 1.07 (1.02, 1.09), p = 0.009), arrhythmias (OR 1.05 (1.02, 1.06), p = 0.0007), and IHD (OR 1.05 (1.01, 1.06), p = 0.036). No significant associations were identified between RA and CMR phenotypes.

conclusionsPeople with RA have a heightened risk of multiple prevalent and incident CVDs, independent of shared risk factors, with suggestions of causal links with IHD, AMI, and arrhythmias.

Indexed as

Arthritis, RheumatoidCardiovascular DiseasesAgedBiological Specimen BanksCase-Control StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedProspective StudiesRisk FactorsUK BiobankUnited KingdomCardiovascular diseaseCausal associationEpidemiologyIschaemic heart diseaseMendelian randomisationPericardial diseaseRheumatoid arthritisRisk factorsUK Biobank

Identifiers

PMID41184868
PMCPMC12581239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.